Phenytoin (All indications)

Low birth weight (< 2500g)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S9275
R32160
Kilic (Phenytoin) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2014 Low birth weight (< 2500 g) during pregnancy (anytime or not specified) population based cohort retrospective exposed to other treatment, sick excluded Adjustment: No 4.31 [0.47;39.33] C
excluded (control group)
1/5   48/876 49 5
ref
S9276
R32163
Kilic (Phenytoin) (Controls unexposed NOS) (Mixed indications), 2014 Low birth weight (< 2500 g) during pregnancy (anytime or not specified) population based cohort retrospective unexposed (general population or NOS) excluded Adjustment: No 6.92 [0.77;61.90] C
excluded (control group)
1/5   23,503/673,844 23,504 5
ref
S9277
R32166
Kilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014 Low birth weight (< 2500 g) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: No Controls: epilepsy indication 5.05 [0.56;45.32] C 1/5   249/5,275 250 5
ref
S9187
R31778
Artama (Phenytoin) (Controls exposed to Lamotrigine, sick), 2013 Low birth weight (< 2500g) during pregnancy (anytime or not specified) population based cohort retrospective exposed to other treatment, sick excluded Adjustment: No 1.11 [0.13;9.64] C
excluded (control group)
1/26   6/173 7 26
ref
S9188
R31790
Artama (Phenytoin) (Controls unexposed, disease free), 2013 Low birth weight (< 2500g) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, disease free excluded Adjustment: Yes 1.33 [0.18;9.92]
excluded (control group)
1/26   21,546/719,509 21,547 26
ref
S9190
R31814
Artama (Phenytoin) (Controls unexposed, sick), 2013 Low birth weight (< 2500g) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: Yes 0.99 [0.13;7.66] 1/26   65/1,793 66 26
ref
Total 2 studies 2.12 [0.43;10.42] 316 31
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Kilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014Kilic, 2014 1 5.05[0.56; 45.32]250547%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Artama (Phenytoin) (Controls unexposed, sick), 2013Artama, 2013 2 0.99[0.13; 7.66]662653%ROB confusion: moderateROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Total (2 studies) I2 = 12% 2.12[0.43; 10.42]316310.220.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Phenytoin) (Controls unexposed, sick) (Mixed indications; 2: Phenytoin) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.12[0.43; 10.42]3163112%NAKilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014 Artama (Phenytoin) (Controls unexposed, sick), 2013 2 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 2.12[0.43; 10.42]3163112%NAKilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014 Artama (Phenytoin) (Controls unexposed, sick), 2013 2 Tags Adjustment   - No  - No 5.05[0.56; 45.32]2505 -NAKilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014 1   - Yes  - Yes 0.99[0.13; 7.60]6626 -NAArtama (Phenytoin) (Controls unexposed, sick), 2013 1 Controls   - epilepsy indication  - epilepsy indication 5.05[0.56; 45.32]2505 -NAKilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014 1 All studiesAll studies 2.12[0.43; 10.42]3163112%NAKilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014 Artama (Phenytoin) (Controls unexposed, sick), 2013 20.220.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 9187, 9188, 9275, 9276

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 2.85[0.57; 14.28]45,0513116%NAKilic (Phenytoin) (Controls unexposed NOS) (Mixed indications), 2014 Artama (Phenytoin) (Controls unexposed, disease free), 2013 2 unexposed, sick controlsunexposed, sick controls 2.12[0.43; 10.42]3163112%NAKilic (Phenytoin) (Controls unexposed, sick) (Mixed indications), 2014 Artama (Phenytoin) (Controls unexposed, sick), 2013 2 exposed to other treatment, sick controlsexposed to other treatment, sick controls 2.16[0.46; 10.10]56310%NAKilic (Phenytoin) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2014 Artama (Phenytoin) (Controls exposed to Lamotrigine, sick), 2013 20.510.01.0